Tonix Pharmaceuticals Holding (TNXP) Inventory (2023 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Inventory of $3.6 million for Q1 2026, down 55.2% year-over-year from $8.1 million in Q1 2025, and up 264.5% quarter-over-quarter from $1.0 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Inventory (2023 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Inventory history runs 4 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- In Q1 2026, Inventory fell 55.2% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (down 55.2% YoY), while the FY2025 annual figure was $1.0 million, down 88.11% from the prior year.
- Inventory for Q1 2026 stood at $3.6 million, up from $1.0 million in the prior quarter.
- The five-year high for Inventory was $13.7 million in Q2 2023, with the low at $339000.0 in Q3 2024.
- The 4-year median for Inventory is $7.1 million (2025), against an average of $6.9 million.
- The sharpest annual moves came in 2024 and 2025: Inventory sank 97.46% in 2024, then soared 1589.97% in 2025.
- Tonix Pharmaceuticals Holding's Inventory stood at $508000.0 in 2023, then jumped by 1555.12% to $8.4 million in 2024, then slumped by 88.11% to $1.0 million in 2025, then jumped by 264.5% to $3.6 million in 2026.
- Business Quant data shows TNXP's Inventory at $3.6 million in Q1 2026, $1.0 million in Q4 2025, and $5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 4.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.68 Mn |
| Mar 31, 2026 | 3.65 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 8.14 Mn |
| Dec 31, 2024 | 8.41 Mn |
| Sep 30, 2024 | 339,000.00 |
| Jun 30, 2024 | 9.46 Mn |
| Mar 31, 2024 | 12.35 Mn |
| Dec 31, 2023 | 508,000.00 |
| Sep 30, 2023 | 13.34 Mn |
| Jun 30, 2023 | 13.70 Mn |